Injectable botulinum toxin was associated with significant efficacy and sufficient safety outcomes in treating patients with androgenetic alopecia.

LEXX READ THE FULL LEXX RESEARCH REPORT Lexaria Bioscience Corporation (NASDAQ:LEXX) reported fiscal first quarter 2025 results along with program updates, progress in its GLP-1 trials, a capital ...